|
1
|
Risebrough NA, Briggs A, Baker TM, Exuzides A, Colby C, Rutten van-Molken M, Gonzalez McQuire S, Lomas D, Muellerova H, Tal-Singer R, Ismaila A. Validating A Model To Predict Disease Progression Outcomes In Patients With COPD. Value Health 2014; 17:A560-A561. [PMID: 27201846 DOI: 10.1016/j.jval.2014.08.1852] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- N A Risebrough
- ICON plc (formerly Oxford Outcomes), Toronto, ON, Canada
| | - A Briggs
- University of Glasgow, Glasgow, UK
| | - T M Baker
- ICON plc (formerly Oxford Outcomes), Morristown, NJ, USA
| | | | - C Colby
- ICON plc, San Francisco, CA, USA
| | | | | | - D Lomas
- University College London, London, UK
| | | | | | - A Ismaila
- GlaxoSmithKline, Research Triangle Park, NC, USA
| |
Collapse
|